T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$3.3B |
| 2 |
Eli Lilly
LLY
|
+$2.75B |
| 3 |
AstraZeneca
AZN
|
+$1.98B |
| 4 |
Coupang
CPNG
|
+$1.54B |
| 5 |
Fortinet
FTNT
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$2.34B |
| 2 |
Morgan Stanley
MS
|
+$2.26B |
| 3 |
Airbnb
ABNB
|
+$2.04B |
| 4 |
Qualcomm
QCOM
|
+$1.95B |
| 5 |
NVIDIA
NVDA
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.55% |
| 2 | Healthcare | 16.29% |
| 3 | Consumer Discretionary | 15.56% |
| 4 | Financials | 12.85% |
| 5 | Communication Services | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TWOU
1801
DELISTED
2U Inc
TWOU
| $1.65M | ﹤0.01% |
1,437
+119
| +9% | +$151K |
|
|
TRTN
1802
DELISTED
Triton International Limited
TRTN
| $1.65M | ﹤0.01% |
29,978
+3,000
| +11% | +$160K |
|
1803
QuantumScape Corp
QS
$3.8B
| $1.64M | ﹤0.01% |
+36,600
| New | +$1.92M |
|
1804
Cheesecake Factory
CAKE
$5.57B
| $1.63M | ﹤0.01% |
27,931
-319
| -1% | -$16.1K |
|
1805
Navient
NAVI
$836M
| $1.63M | ﹤0.01% |
114,163
+7,158
| +7% | +$88.1K |
|
|
BCPC
1806
Balchem Corp
BCPC
$5.65B
| $1.63M | ﹤0.01% |
13,026
+104
| +0.8% | +$12.6K |
|
1807
OraSure Technologies
OSUR
$273M
| $1.61M | ﹤0.01% |
138,266
-9,638
| -7% | -$118K |
|
1808
Evercore
EVR
$11.8B
| $1.61M | ﹤0.01% |
12,242
+279
| +2% | +$34.1K |
|
1809
Check Point Software Technologies
CHKP
$13.5B
| $1.61M | ﹤0.01% |
14,373
+4
| +0% | +$482 |
|
|
FLNA
1810
Filana Therapeutics
FLNA
$44.1M
| $1.6M | ﹤0.01% |
35,706
+22,209
| +165% | +$873K |
|
1811
Ashland
ASH
$3.35B
| $1.6M | ﹤0.01% |
18,024
+2,562
| +17% | +$221K |
|
|
UCTT
1812
Ultra Clean Holdings
UCTT
$3.91B
| $1.59M | ﹤0.01% |
27,420
+10,422
| +61% | +$480K |
|
1813
Amkor Technology
AMKR
$14.5B
| $1.58M | ﹤0.01% |
66,748
-15,577
| -19% | -$319K |
|
1814
NBT Bancorp
NBTB
$2.79B
| $1.58M | ﹤0.01% |
39,548
-9
| -0% | -$331 |
|
1815
KBR
KBR
$4.84B
| $1.58M | ﹤0.01% |
41,058
+5,286
| +15% | +$169K |
|
1816
Sally Beauty Holdings
SBH
$1.52B
| $1.57M | ﹤0.01% |
77,826
+10,407
| +15% | +$174K |
|
1817
Enpro
NPO
$7.21B
| $1.56M | ﹤0.01% |
18,359
-213,071
| -92% | -$17.4M |
|
1818
CryoPort
CYRX
$762M
| $1.56M | ﹤0.01% |
30,046
+7,166
| +31% | +$436K |
|
1819
Fresenius Medical Care
FMS
$12.6B
| $1.56M | ﹤0.01% |
+42,352
| New | +$1.6M |
|
1820
Ligand Pharmaceuticals
LGND
$5.87B
| $1.56M | ﹤0.01% |
16,423
-85,877
| -84% | -$8.12M |
|
|
RWT
1821
Redwood Trust
RWT
$604M
| $1.56M | ﹤0.01% |
149,636
+14,574
| +11% | +$140K |
|
1822
Rithm Capital
RITM
$5.79B
| $1.56M | ﹤0.01% |
138,444
+7,156
| +5% | +$72.8K |
|
1823
Cannae Holdings
CNNE
$651M
| $1.55M | ﹤0.01% |
39,223
-726,498
| -95% | -$29.4M |
|
1824
City Holding Co
CHCO
$2.08B
| $1.55M | ﹤0.01% |
18,976
-2,028
| -10% | -$154K |
|
1825
Milestone Pharmaceuticals
MIST
$133M
| $1.55M | ﹤0.01% |
267,997
-106,960
| -29% | -$783K |
|
Similar funds
T. Rowe Price Associates's Q1 2021 Portfolio in Review
As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
- T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
- T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
- T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
- T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
- T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.